The efficiency of Rosiglitazone versus Metformin combined with Clomiphene Citrate in induction of ovulation in cases with polycystic ovary syndrome
Alaa El-Din Omar El-Halaby;
Abstract
Clomiphene citrate (CC) is currently the first-line therapeutic modality for women with infertility and PCOS. Ovulation occurs in 70%–85% of women, but 33%–45% achieve pregnancy. (7)
If CC does result in ovulation, the American College of Obstetricians an
If CC does result in ovulation, the American College of Obstetricians an
Other data
| Title | The efficiency of Rosiglitazone versus Metformin combined with Clomiphene Citrate in induction of ovulation in cases with polycystic ovary syndrome | Authors | Alaa El-Din Omar El-Halaby | Keywords | The efficiency of Rosiglitazone versus Metformin combined with Clomiphene Citrate in induction of ovulation in cases with polycystic ovary syndrome | Issue Date | 2008 | Description | Clomiphene citrate (CC) is currently the first-line therapeutic modality for women with infertility and PCOS. Ovulation occurs in 70%–85% of women, but 33%–45% achieve pregnancy. (7) If CC does result in ovulation, the American College of Obstetricians an |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.